Dishman Carbogen Amcis planning to invest $50 million in France to set up new facility

21 Oct 2021 Evaluate

Dishman Carbogen Amcis (DCAL) is planning to invest $ 50 million in France to set up a new facility for manufacturing formulated products, mainly in the form of parenterals. The new facility would begin commercial production from January 2023 with two manufacturing lines.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

158.55 -5.25 (-3.21%)
09-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.60
Dr. Reddys Lab 1286.40
Cipla 1325.15
Zydus Lifesciences 908.65
Lupin 2301.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×